hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)
1
relevant articles (1 outcomes,
1 trials/studies)
found for this Bio-Agent
Also Known As:
(HC)-(OP(D-Cha)WR); HC-(OPChaWR)
Relationship Network
Bio-Agent Context: Research Results
Related Diseases
| 1. | Colitis
08/01/2005
- " This study tested the efficacy and potency of a new C5a antagonist, hydrocinnamate (HC)-[OP(d-Cha)WR], which has limited intestinal lumenal metabolism, in this model of colitis" 08/01/2005
- " These studies suggest that resistance to intestinal metabolism by HC-[OP(d-Cha)WR] may result in increased local concentrations of the drug in the colon, thus affording efficacy with markedly lower oral doses than AcF-[OP(d-Cha)WR] against TNBS-colitis" 08/01/2005
- " One metabolically stable analog, HC-[OP(d-Cha)WR], was then evaluated pharmacokinetically and investigated at a range of doses (0.03-10 mg/kg/day p.o.) in the 8-day rat TNBS-colitis model, against the comparator drug AcF-[OP(d-Cha)WR]" 08/01/2005
- " However, in the rat TNBS-colitis model, HC-[OP(d-Cha)WR] was effective at reducing mortality, colon edema, colon macroscopic scores, and increasing food consumption and body weights, at 10- to 30-fold lower oral doses than AcF-[OP(d-Cha)WR]"
Get all the results and reference details, order at left...
|
| 2. | Edema
|
| 3. | Body Weight (Weight, Body)
|
| 3 Diseases
and
1
more articles analyzed in the Research Interface, order at left...
|
Related Drugs and Biologics